Treatment Trials

1 Clinical Trials for Various Conditions

Focus your search

      RECRUITING
      One-month Latent Tuberculosis Treatment for Renal Transplant Candidates
      Description

      This is a prospective, single-center, single-arm, open-label study investigating the safety, compliance and pharmacokinetics of 1-month treatment of Isoniazid, Rifapentine and Vitamin B6 in renal transplant candidates.

      Conditions
      Latent TuberculosisEnd Stage Renal DiseaseRenal Transplant Candidate for Right KidneyRenal Transplant Candidate for Left Kidney
      Talk to us